Loading…

Mulitiple primary cancers in familes with Li-Fraumeni syndrome

BACKGROUND: Li-Fraumeni syndrome is a dominantly inherited disorder characterized by early-onset breast cancer, sarcomas, and other cancers in children and young adults. Members of families with this syndrome also develop multiple primary cancers, but the frequency is unknown. To approach this issue...

Full description

Saved in:
Bibliographic Details
Published in:JNCI : Journal of the National Cancer Institute 1998-04, Vol.90 (8), p.606
Main Authors: Hisada, Michie, Garber, Judy E, Fung, Claire Y, Fraumeni, Joseph F, Li, Frederick P
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 8
container_start_page 606
container_title JNCI : Journal of the National Cancer Institute
container_volume 90
creator Hisada, Michie
Garber, Judy E
Fung, Claire Y
Fraumeni, Joseph F
Li, Frederick P
description BACKGROUND: Li-Fraumeni syndrome is a dominantly inherited disorder characterized by early-onset breast cancer, sarcomas, and other cancers in children and young adults. Members of families with this syndrome also develop multiple primary cancers, but the frequency is unknown. To approach this issue, we quantified the incidence of second and third primary cancers in individuals from 24 Li-Fraumeni kindreds originally diagnosed with cancer during the period from 1968 through 1986. METHODS: The relative risk (RR) of subsequent cancers and 95% confidence intervals (CIs) were calculated by use of population-based incidence data from the Connecticut Cancer Registry. Kaplan-Meier analysis was used to determine the cumulative probability (+/- standard error) of subsequent cancers. RESULTS: Among 200 Li-Fraumeni syndrome family members diagnosed with cancer, 30 (15%) developed a second cancer. Eight individuals (4%) had a third cancer, while four (2%) eventually developed a fourth cancer. Overall, the RR of occurrence of a second cancer was 5.3 (95% CI = 2.8-7.8), with a cumulative probability of second cancer occurrence of 57% (+/- 10%) at 30 years after diagnosis of a first cancer. RRs of second cancers occurring in families with this syndrome were 83.0 (95% CI = 36.9-187.6), 9.7 (95% CI = 4.9-19.2), and 1.5 (95% CI = 0.5-4.2) for individuals with a first cancer at ages 0-19 years, 20-44 years, and 45 years or more, respectively. Thirty (71%) of 42 subsequent cancers in this group were component cancers of Li-Fraumeni syndrome. CONCLUSIONS: Compared with the general population, members of Li-Fraumeni syndrome families have an exceptionally high risk of developing multiple primary cancers. The excess risk of additional primary cancers is mainly for cancers that are characteristic of Li-Fraumeni syndrome, with the highest risk observed for survivors of childhood cancers. Cancer survivors in these families should be closely monitored for early manifestations of new cancers.
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_220977292</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>28694891</sourcerecordid><originalsourceid>FETCH-proquest_journals_2209772923</originalsourceid><addsrcrecordid>eNqNirsKwjAUQIMoWB__ENwDaaymXVzE4qCbewn1Fm9J0prbIP17O_gBnuUM58xYkmZHKVQqD3OWSKm0yHOdLdmKqJUThcoSdrpHiwP2Fngf0Jkw8tr4GgJx9LwxDi0Q_-Dw4jcUZTDRgUdOo3-GzsGGLRpjCbY_r9muvDzOV9GH7h2BhqrtYvBTqpSShdaqUPu_pi9Q7Dld</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>220977292</pqid></control><display><type>article</type><title>Mulitiple primary cancers in familes with Li-Fraumeni syndrome</title><source>Oxford Journals Online</source><creator>Hisada, Michie ; Garber, Judy E ; Fung, Claire Y ; Fraumeni, Joseph F ; Li, Frederick P</creator><creatorcontrib>Hisada, Michie ; Garber, Judy E ; Fung, Claire Y ; Fraumeni, Joseph F ; Li, Frederick P</creatorcontrib><description>BACKGROUND: Li-Fraumeni syndrome is a dominantly inherited disorder characterized by early-onset breast cancer, sarcomas, and other cancers in children and young adults. Members of families with this syndrome also develop multiple primary cancers, but the frequency is unknown. To approach this issue, we quantified the incidence of second and third primary cancers in individuals from 24 Li-Fraumeni kindreds originally diagnosed with cancer during the period from 1968 through 1986. METHODS: The relative risk (RR) of subsequent cancers and 95% confidence intervals (CIs) were calculated by use of population-based incidence data from the Connecticut Cancer Registry. Kaplan-Meier analysis was used to determine the cumulative probability (+/- standard error) of subsequent cancers. RESULTS: Among 200 Li-Fraumeni syndrome family members diagnosed with cancer, 30 (15%) developed a second cancer. Eight individuals (4%) had a third cancer, while four (2%) eventually developed a fourth cancer. Overall, the RR of occurrence of a second cancer was 5.3 (95% CI = 2.8-7.8), with a cumulative probability of second cancer occurrence of 57% (+/- 10%) at 30 years after diagnosis of a first cancer. RRs of second cancers occurring in families with this syndrome were 83.0 (95% CI = 36.9-187.6), 9.7 (95% CI = 4.9-19.2), and 1.5 (95% CI = 0.5-4.2) for individuals with a first cancer at ages 0-19 years, 20-44 years, and 45 years or more, respectively. Thirty (71%) of 42 subsequent cancers in this group were component cancers of Li-Fraumeni syndrome. CONCLUSIONS: Compared with the general population, members of Li-Fraumeni syndrome families have an exceptionally high risk of developing multiple primary cancers. The excess risk of additional primary cancers is mainly for cancers that are characteristic of Li-Fraumeni syndrome, with the highest risk observed for survivors of childhood cancers. Cancer survivors in these families should be closely monitored for early manifestations of new cancers.</description><identifier>ISSN: 0027-8874</identifier><identifier>EISSN: 1460-2105</identifier><identifier>CODEN: JNCIEQ</identifier><language>eng</language><publisher>Oxford: Oxford Publishing Limited (England)</publisher><subject>Cancer ; Genetics ; Medical research</subject><ispartof>JNCI : Journal of the National Cancer Institute, 1998-04, Vol.90 (8), p.606</ispartof><rights>Copyright Superintendent of Documents Apr 15, 1998</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Hisada, Michie</creatorcontrib><creatorcontrib>Garber, Judy E</creatorcontrib><creatorcontrib>Fung, Claire Y</creatorcontrib><creatorcontrib>Fraumeni, Joseph F</creatorcontrib><creatorcontrib>Li, Frederick P</creatorcontrib><title>Mulitiple primary cancers in familes with Li-Fraumeni syndrome</title><title>JNCI : Journal of the National Cancer Institute</title><description>BACKGROUND: Li-Fraumeni syndrome is a dominantly inherited disorder characterized by early-onset breast cancer, sarcomas, and other cancers in children and young adults. Members of families with this syndrome also develop multiple primary cancers, but the frequency is unknown. To approach this issue, we quantified the incidence of second and third primary cancers in individuals from 24 Li-Fraumeni kindreds originally diagnosed with cancer during the period from 1968 through 1986. METHODS: The relative risk (RR) of subsequent cancers and 95% confidence intervals (CIs) were calculated by use of population-based incidence data from the Connecticut Cancer Registry. Kaplan-Meier analysis was used to determine the cumulative probability (+/- standard error) of subsequent cancers. RESULTS: Among 200 Li-Fraumeni syndrome family members diagnosed with cancer, 30 (15%) developed a second cancer. Eight individuals (4%) had a third cancer, while four (2%) eventually developed a fourth cancer. Overall, the RR of occurrence of a second cancer was 5.3 (95% CI = 2.8-7.8), with a cumulative probability of second cancer occurrence of 57% (+/- 10%) at 30 years after diagnosis of a first cancer. RRs of second cancers occurring in families with this syndrome were 83.0 (95% CI = 36.9-187.6), 9.7 (95% CI = 4.9-19.2), and 1.5 (95% CI = 0.5-4.2) for individuals with a first cancer at ages 0-19 years, 20-44 years, and 45 years or more, respectively. Thirty (71%) of 42 subsequent cancers in this group were component cancers of Li-Fraumeni syndrome. CONCLUSIONS: Compared with the general population, members of Li-Fraumeni syndrome families have an exceptionally high risk of developing multiple primary cancers. The excess risk of additional primary cancers is mainly for cancers that are characteristic of Li-Fraumeni syndrome, with the highest risk observed for survivors of childhood cancers. Cancer survivors in these families should be closely monitored for early manifestations of new cancers.</description><subject>Cancer</subject><subject>Genetics</subject><subject>Medical research</subject><issn>0027-8874</issn><issn>1460-2105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqNirsKwjAUQIMoWB__ENwDaaymXVzE4qCbewn1Fm9J0prbIP17O_gBnuUM58xYkmZHKVQqD3OWSKm0yHOdLdmKqJUThcoSdrpHiwP2Fngf0Jkw8tr4GgJx9LwxDi0Q_-Dw4jcUZTDRgUdOo3-GzsGGLRpjCbY_r9muvDzOV9GH7h2BhqrtYvBTqpSShdaqUPu_pi9Q7Dld</recordid><startdate>19980415</startdate><enddate>19980415</enddate><creator>Hisada, Michie</creator><creator>Garber, Judy E</creator><creator>Fung, Claire Y</creator><creator>Fraumeni, Joseph F</creator><creator>Li, Frederick P</creator><general>Oxford Publishing Limited (England)</general><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>19980415</creationdate><title>Mulitiple primary cancers in familes with Li-Fraumeni syndrome</title><author>Hisada, Michie ; Garber, Judy E ; Fung, Claire Y ; Fraumeni, Joseph F ; Li, Frederick P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_2209772923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Cancer</topic><topic>Genetics</topic><topic>Medical research</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hisada, Michie</creatorcontrib><creatorcontrib>Garber, Judy E</creatorcontrib><creatorcontrib>Fung, Claire Y</creatorcontrib><creatorcontrib>Fraumeni, Joseph F</creatorcontrib><creatorcontrib>Li, Frederick P</creatorcontrib><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>JNCI : Journal of the National Cancer Institute</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hisada, Michie</au><au>Garber, Judy E</au><au>Fung, Claire Y</au><au>Fraumeni, Joseph F</au><au>Li, Frederick P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mulitiple primary cancers in familes with Li-Fraumeni syndrome</atitle><jtitle>JNCI : Journal of the National Cancer Institute</jtitle><date>1998-04-15</date><risdate>1998</risdate><volume>90</volume><issue>8</issue><spage>606</spage><pages>606-</pages><issn>0027-8874</issn><eissn>1460-2105</eissn><coden>JNCIEQ</coden><abstract>BACKGROUND: Li-Fraumeni syndrome is a dominantly inherited disorder characterized by early-onset breast cancer, sarcomas, and other cancers in children and young adults. Members of families with this syndrome also develop multiple primary cancers, but the frequency is unknown. To approach this issue, we quantified the incidence of second and third primary cancers in individuals from 24 Li-Fraumeni kindreds originally diagnosed with cancer during the period from 1968 through 1986. METHODS: The relative risk (RR) of subsequent cancers and 95% confidence intervals (CIs) were calculated by use of population-based incidence data from the Connecticut Cancer Registry. Kaplan-Meier analysis was used to determine the cumulative probability (+/- standard error) of subsequent cancers. RESULTS: Among 200 Li-Fraumeni syndrome family members diagnosed with cancer, 30 (15%) developed a second cancer. Eight individuals (4%) had a third cancer, while four (2%) eventually developed a fourth cancer. Overall, the RR of occurrence of a second cancer was 5.3 (95% CI = 2.8-7.8), with a cumulative probability of second cancer occurrence of 57% (+/- 10%) at 30 years after diagnosis of a first cancer. RRs of second cancers occurring in families with this syndrome were 83.0 (95% CI = 36.9-187.6), 9.7 (95% CI = 4.9-19.2), and 1.5 (95% CI = 0.5-4.2) for individuals with a first cancer at ages 0-19 years, 20-44 years, and 45 years or more, respectively. Thirty (71%) of 42 subsequent cancers in this group were component cancers of Li-Fraumeni syndrome. CONCLUSIONS: Compared with the general population, members of Li-Fraumeni syndrome families have an exceptionally high risk of developing multiple primary cancers. The excess risk of additional primary cancers is mainly for cancers that are characteristic of Li-Fraumeni syndrome, with the highest risk observed for survivors of childhood cancers. Cancer survivors in these families should be closely monitored for early manifestations of new cancers.</abstract><cop>Oxford</cop><pub>Oxford Publishing Limited (England)</pub></addata></record>
fulltext fulltext
identifier ISSN: 0027-8874
ispartof JNCI : Journal of the National Cancer Institute, 1998-04, Vol.90 (8), p.606
issn 0027-8874
1460-2105
language eng
recordid cdi_proquest_journals_220977292
source Oxford Journals Online
subjects Cancer
Genetics
Medical research
title Mulitiple primary cancers in familes with Li-Fraumeni syndrome
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A21%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mulitiple%20primary%20cancers%20in%20familes%20with%20Li-Fraumeni%20syndrome&rft.jtitle=JNCI%20:%20Journal%20of%20the%20National%20Cancer%20Institute&rft.au=Hisada,%20Michie&rft.date=1998-04-15&rft.volume=90&rft.issue=8&rft.spage=606&rft.pages=606-&rft.issn=0027-8874&rft.eissn=1460-2105&rft.coden=JNCIEQ&rft_id=info:doi/&rft_dat=%3Cproquest%3E28694891%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_2209772923%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=220977292&rft_id=info:pmid/&rfr_iscdi=true